Welcome To ChemAnalyst
In September 2025, India experiencing moderate increases in Di-tert-Butyl Phenol (DTBP) prices, which rose 0.46% ex-Mumbai and 0.55% for CFR imports, supported by strong downstream demand, despite the more uninhibited flow of imports into India due to congestion at the Qingdao port. Heavy dependency on imports from Taiwan and China faced pressure given prior delays in Chinese loadings due to volume, creating supply constraints that have underpinned price firmness. There was strong growth in the antioxidants market regarding investments made in the food processing sector, pharmaceuticals, cosmetics, and animal feed sectors that drove demand resilience.
Indiax;s demand for DTBP in September xxxx was strong in multiple antioxidants applications such as food & beverages, pharmaceuticals, cosmetics, and animal feed due to a x.xx increase of the IPM now valued at Rs. xx,xxx crore (Rs.xx,xxx crore in food & beverages, Rs.x,xxx crore in pharmaceuticals, Rs.xxx crore in cosmetics, and Rs.xxx crore in animal feed). DTBP demand grew by x.xx, driven by new chronic therapy products for cardiac, anti-diabetic, and respiratory segments which accounted for x.xx of the DTBP demand. Additionally, clean-label ingredients along with government investments in food processing contributed to the DTBP price uptick. While some sectors like gastrointestinal and analgesics witness reduced volumes, and export prices remained well priced with consistent internal transportation availability. Repurposed domestic logistics relieved bottlenecks, while imports were delayed due to congestion of the Qingdao port in China, moreover India limited DTBP imports from Taiwan. In response to industry...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.